학술논문
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data from the I-SPY2 Randomized Clinical Trial
Document Type
Article
Author
Symmans, W.F.; Yau, C.; Shad, S.; Matthews, J.B.; Esserman, L.J.; Chen, Y.-Y.; Balassanian, R.; Krings, G.; Klein, M.E.; Pusztai, L.; Nanda, R.; Parker, B.A.; Schwab, R.B.; Helsten, T.; Datnow, B.; Wei, S.; Feldman, M.D.; Duan, X.; Chen, B.; Sattar, H.; Khazai, L.; Zeck, J.C.; Sams, S.; Mhawech-Fauceglia, P.; Rendi, M.; Sahoo, S.; Ocal, I.T.; Fan, F.; Lebeau, L.G.; Vinh, T.; Troxell, M.L.; Chien, A.J.; Rugo, H.S.; Wallace, A.M.; Forero-Torres, A.; Ellis, E.; Albain, K.S.; Murthy, R.K.; Boughey, J.C.; Liu, M.C.; Haley, B.B.; Elias, A.D.; Clark, A.S.; Demichele, A.M.; Kemmer, K.; Isaacs, C.; Lang, J.E.; Han, H.S.; Edmiston, K.; Viscusi, R.K.; Northfelt, D.W.; Khan, Q.J.; Leyland-Jones, B.; Venters, S.J.; Van 'T Veer, L.; Asare, S.M.; Asare, A.L.; Buxton, M.; Berry, D.A.; Hylton, N.M.; Perlmutter, J.; Yee, D.
Source
In: JAMA Oncology . (JAMA Oncology, November 2021, 7(11):1654-1663)
Subject
Language
English
ISSN
23742445
23742437
23742437